Physician profile
Travis Johnson
NPI 1013405778
$530.01
in general payments reported to CMS, 2019-2025
13 companies · $33.08 in 2025
The $33.08 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.65 · 2022: $180 · 2023: $217 · 2024: $72.67 · 2025: $33.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $158.15 | 2022-2024 | Jornay Pm |
| Allergan, INC. | $106.81 | 2022 | |
| Merck Sharp & Dohme LLC | $59.83 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Neurelis, INC. | $32.45 | 2023 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $30.13 | 2021-2023 | Trintellix |
| Amgen INC. | $24.11 | 2024 | Tezspire |
| Sanofi Pasteur INC. | $23.71 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.41 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $17.37 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $15.96 | 2023 | Emgality |
| Exact Sciences Corporation | $15.67 | 2025 | Cologuard Collection Kit |
| Tris Pharma INC | $15.05 | 2024 | Dyanavel Xr |
| Esperion Therapeutics, INC. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.